Banco Pichincha S.A. (BVL:BPICHC1)
Peru · Delayed Price · Currency is PEN 0.2000
0.00 (0.00%)
At close: Jul 30, 2025, 2:52 PM PET
Sage Therapeutics Income Statement
Financials in millions PEN. Fiscal year is January - December.
Millions PEN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Interest Income on Loans | 888.64 | 917.84 | 1,066 | 983.05 | 843.9 | 841.01 | Upgrade |
Interest Income on Investments | 112.3 | 111.19 | 83.01 | 43.61 | 11.96 | 18.08 | Upgrade |
Total Interest Income | 1,001 | 1,029 | 1,149 | 1,027 | 855.85 | 859.09 | Upgrade |
Interest Paid on Deposits | 322.48 | 356.5 | 390.77 | 226.5 | 157.75 | 206.62 | Upgrade |
Interest Paid on Borrowings | 107.17 | 109.99 | 132.88 | 116.93 | 110.5 | 112.28 | Upgrade |
Total Interest Expense | 429.65 | 466.5 | 523.65 | 343.44 | 268.25 | 318.9 | Upgrade |
Net Interest Income | 571.29 | 562.53 | 625.57 | 683.22 | 587.6 | 540.19 | Upgrade |
Net Interest Income Growth (YoY) | -4.08% | -10.08% | -8.44% | 16.27% | 8.78% | -12.39% | Upgrade |
Gain (Loss) on Sale of Assets | 12.04 | 12.05 | 30.42 | -0.99 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -1.57 | -1.57 | -0.96 | -1.32 | -1.32 | -5.32 | Upgrade |
Gain (Loss) on Sale of Equity Investments | -0 | - | - | -0.09 | 0.62 | 0.07 | Upgrade |
Other Non-Interest Income | 108.29 | 128.22 | 181.77 | 127.1 | 130.53 | 116.96 | Upgrade |
Total Non-Interest Income | 145.21 | 165.15 | 233.71 | 130.28 | 151.46 | 117.7 | Upgrade |
Non-Interest Income Growth (YoY) | -40.16% | -29.34% | 79.38% | -13.98% | 28.68% | -5.84% | Upgrade |
Revenues Before Loan Losses | 716.5 | 727.68 | 859.27 | 813.5 | 739.06 | 657.89 | Upgrade |
Provision for Loan Losses | 518.66 | 605.32 | 485.2 | 401.22 | 442.22 | 292.22 | Upgrade |
| 197.83 | 122.37 | 374.07 | 412.28 | 296.85 | 365.67 | Upgrade | |
Revenue Growth (YoY) | -26.09% | -67.29% | -9.27% | 38.89% | -18.82% | -19.50% | Upgrade |
Salaries and Employee Benefits | 150.12 | 159.51 | 172.52 | 166.34 | 197.34 | 175.73 | Upgrade |
Occupancy Expenses | 18.76 | 19.07 | 15.99 | 15.24 | 18.59 | 18.6 | Upgrade |
Selling, General & Administrative | 117.56 | 123.49 | 143.91 | 157.85 | 183.73 | 172.76 | Upgrade |
Other Non-Interest Expense | 11.06 | 11.78 | 45.57 | 65.49 | 46.08 | 24.21 | Upgrade |
Total Non-Interest Expense | 297.7 | 317.87 | 378.88 | 410.84 | 448.29 | 393.34 | Upgrade |
EBT Excluding Unusual Items | -99.87 | -195.5 | -4.8 | 1.44 | -151.44 | -27.67 | Upgrade |
Legal Settlements | -12.34 | -12.26 | -7.78 | -0.95 | -0.53 | -0.52 | Upgrade |
Other Unusual Items | 78.08 | 124.73 | 10.13 | 7.45 | 14.39 | 6.41 | Upgrade |
Pretax Income | -34.11 | -83.02 | -2.46 | 7.94 | -137.58 | -21.78 | Upgrade |
Income Tax Expense | -26.85 | -24.41 | -3.09 | 2.88 | -33.46 | 0.32 | Upgrade |
Earnings From Continuing Operations | -7.26 | -58.61 | 0.63 | 5.06 | -104.11 | -22.09 | Upgrade |
Minority Interest in Earnings | - | - | - | - | 6.34 | -0.64 | Upgrade |
Net Income | -7.26 | -58.61 | 0.63 | 5.06 | -97.77 | -22.74 | Upgrade |
Net Income to Common | -7.26 | -58.61 | 0.63 | 5.06 | -97.77 | -22.74 | Upgrade |
Net Income Growth | - | - | -87.53% | - | - | - | Upgrade |
Basic Shares Outstanding | 1,263 | 1,257 | 1,188 | 1,024 | 882 | 861 | Upgrade |
Diluted Shares Outstanding | 1,263 | 1,257 | 1,188 | 1,024 | 882 | 861 | Upgrade |
Shares Change (YoY) | 2.75% | 5.85% | 16.00% | 16.05% | 2.53% | 21.59% | Upgrade |
EPS (Basic) | -0.01 | -0.05 | 0.00 | 0.00 | -0.11 | -0.03 | Upgrade |
EPS (Diluted) | -0.01 | -0.05 | 0.00 | 0.00 | -0.11 | -0.03 | Upgrade |
EPS Growth | - | - | -89.25% | - | - | - | Upgrade |
Effective Tax Rate | - | - | - | 36.29% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.